Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs

被引：0

作者：

Schultz, RM ^{[1
]}

Chen, VJ ^{[1
]}

Bewley, JR ^{[1
]}

Roberts, EF ^{[1
]}

Shih, C ^{[1
]}

Dempsey, JA ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Canc Res Div, Indianapolis, IN 46285 USA

来源：

SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：68 / 73

页数：6

共 50 条

[41] Phase II study of a multi-targeted antifolate (LY231514) (MTA) as first line therapy in patients with locally advanced or metastatic colorectal cancer (MCC)
Cripps, MC
Burnell, M
Jolivet, J
Lofters, W
Fisher, B
Panasci, L
Iglesias, J
Eisenhauer, E
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 768 - 768
[42] Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines
Smith, PG
Marshman, E
Calvert, AH
Newell, DR
Curtin, NJ
SEMINARS IN ONCOLOGY, 1999, 26 (02) : 63 - 67
[43] Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC)
Rusthoven, J
Eisenhauer, E
Butts, C
Gregg, R
Dancey, J
Fisher, B
Iglesias, J
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1045 - 1045
[44] Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line
Wang, YH
Zhao, RB
Goldman, ID
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (07) : 1163 - 1170
[45] Sequence dependence using combinations of Alimta™ (pemetrexed disodium, LY231514, MTA), gemcitabine, and oxaliplatin in human colorectal carcinoma cell lines.
Schultz, R
Rothenberg, M
Koury, M
Hankins, WD
Kravtsov, V
CLINICAL CANCER RESEARCH, 2000, 6 : 4567S - 4567S
[46] Phase II trial of the multi-targeted antifolate MTA (LY231514) in patients with non-small cell lung cancer (NSCLC) who have failed previous platinum or non-platinum chemotherapy
Mattson, K
Manegold, C
Postmus, P
Smit, E
Millward, M
Saarinen, A
ANNALS OF ONCOLOGY, 1998, 9 : 98 - 98
[47] Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate
Li, WW
Tong, WP
Bertino, JR
CLINICAL CANCER RESEARCH, 1995, 1 (06) : 631 - 636
[48] A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexed
Wang, YH
Zhao, RB
Chattopadhyay, S
Goldman, ID
CANCER RESEARCH, 2002, 62 (22) : 6434 - 6437
[49] Variable expression of the folylpolyglutamate synthetase gene at the level of mRNA transcription in human leukemia cell lines sensitive, or made resistant, to various antifolate drugs
Takemura, Y
Kobayashi, H
Miyachi, H
ANTI-CANCER DRUGS, 1999, 10 (07) : 677 - 683
[50] Induction of apoptosis in colon cancer cell lines by the thymidylate synthase (TS) inhibitors, 5-fluorouracil and AG337 and by MTA (LY231514) is dependent on p53 and probably the bcl-2 status
Backus, HHJ
Wouters, D
Kuiper, CM
Pinedo, HM
van Groeningen, CJ
Peters, GJ
ANNALS OF ONCOLOGY, 1998, 9 : 113 - 113

← 1 2 3 4 5 →